What's in Q32 Bio Inc.'s pipeline?

Q32 Bio Inc. has 1 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Q32 Bio Inc.'s portfolio?

Top competitors by shared drug class: Addrenex Pharmaceuticals, Inc., Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., Juno Therapeutics, Inc., a Bristol-Myers Squibb Company, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/q32-bio-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Q32 Bio Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Q32 Bio Inc. pipeline: 0 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Addrenex Pharmaceuticals, Inc. · 1 shared drug class
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · 1 shared drug class
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · 1 shared drug class
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Q32 Bio Inc.:

Cite this brief

Drug Landscape (2026). Q32 Bio Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/q32-bio-inc. Accessed 2026-06-10.